GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Shiller PE Ratio

Abattis Bioceuticals (Abattis Bioceuticals) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abattis Bioceuticals Shiller PE Ratio Historical Data

The historical data trend for Abattis Bioceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Shiller PE Ratio Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abattis Bioceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abattis Bioceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Shiller PE Ratio falls into.



Abattis Bioceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Abattis Bioceuticals's E10 for the quarter that ended in Sep. 2019 is calculated as:

For example, Abattis Bioceuticals's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.004/107.6113*107.6113
=-0.004

Current CPI (Sep. 2019) = 107.6113.

Abattis Bioceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200912 0.000 90.703 0.000
201003 -0.049 91.335 -0.058
201006 -0.048 91.809 -0.056
201009 -0.097 92.362 -0.113
201012 0.000 92.836 0.000
201103 0.000 94.338 0.000
201106 -0.051 94.654 -0.058
201109 -0.040 95.286 -0.045
201112 -0.010 94.970 -0.011
201203 -0.020 96.155 -0.022
201206 -0.019 96.076 -0.021
201209 -0.041 96.392 -0.046
201212 -0.020 95.760 -0.022
201303 -0.010 97.103 -0.011
201306 -0.010 97.182 -0.011
201309 0.000 97.419 0.000
201312 -0.009 96.945 -0.010
201403 -0.117 98.604 -0.128
201406 -0.009 99.473 -0.010
201409 -0.014 99.394 -0.015
201412 -0.010 98.367 -0.011
201503 -0.008 99.789 -0.009
201506 -0.008 100.500 -0.009
201509 -0.023 100.421 -0.025
201512 -0.007 99.947 -0.008
201603 -0.008 101.054 -0.009
201606 -0.003 102.002 -0.003
201609 -0.015 101.765 -0.016
201612 -0.007 101.449 -0.007
201703 -0.015 102.634 -0.016
201706 -0.015 103.029 -0.016
201709 -0.016 103.345 -0.017
201712 -0.023 103.345 -0.024
201803 -0.031 105.004 -0.032
201806 -0.015 105.557 -0.015
201809 -0.123 105.636 -0.125
201812 -0.002 105.399 -0.002
201903 0.000 106.979 0.000
201906 -0.001 107.690 -0.001
201909 -0.004 107.611 -0.004

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abattis Bioceuticals  (OTCPK:ATTBF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Abattis Bioceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines